25th Feb 2013 09:56
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
Following a revaluation of the cash element of the notional investment held within the US Retirement Savings Plan (The Plan), which is notionally held in GSK American Depositary Shares (ADSs), the Administrators of the Plan notified GlaxoSmithKline plc and the under-mentioned Persons on 22 February 2013 of an increase in the notional allocation of ADSs on 21 February 2013 at a price of $44.77 per ADS:-
Director/PDMR
|
Number of ADSs |
Connected Person |
Number of ADSs | ||
Dr M M Slaoui
|
15 |
Dr K Slaoui |
13 | ||
Mr W C Louv
| 23 | - | - | ||
Mrs D P Connelly
| 1 | - | - | ||
|
| ||||
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a) and (c).
V A Whyte
Company Secretary
25 February 2013
Related Shares:
Glaxosmithkline